Table 3
Open in new tab

Results of the sensitivity analysis.

Outcome phenotypesHeterogeneityPleiotropy
Cochran QPInterceptP
Breast cancer189.05311.55 × 10−150.009.16
Endometrial cancer77.32.060.005.62
Endometriosis123.791.68 × 10−6−0.02.25
Female infertility61.20.40−0.02.11
Ovarian cancer84.25.02−0.004.69
Pre-eclampsia or eclampsia71.32.13−0.091.50
Uterine fibroids79.92.047.17 × 10−5.67
Outcome phenotypesHeterogeneityPleiotropy
Cochran QPInterceptP
Breast cancer189.05311.55 × 10−150.009.16
Endometrial cancer77.32.060.005.62
Endometriosis123.791.68 × 10−6−0.02.25
Female infertility61.20.40−0.02.11
Ovarian cancer84.25.02−0.004.69
Pre-eclampsia or eclampsia71.32.13−0.091.50
Uterine fibroids79.92.047.17 × 10−5.67
Table 3
Open in new tab

Results of the sensitivity analysis.

Outcome phenotypesHeterogeneityPleiotropy
Cochran QPInterceptP
Breast cancer189.05311.55 × 10−150.009.16
Endometrial cancer77.32.060.005.62
Endometriosis123.791.68 × 10−6−0.02.25
Female infertility61.20.40−0.02.11
Ovarian cancer84.25.02−0.004.69
Pre-eclampsia or eclampsia71.32.13−0.091.50
Uterine fibroids79.92.047.17 × 10−5.67
Outcome phenotypesHeterogeneityPleiotropy
Cochran QPInterceptP
Breast cancer189.05311.55 × 10−150.009.16
Endometrial cancer77.32.060.005.62
Endometriosis123.791.68 × 10−6−0.02.25
Female infertility61.20.40−0.02.11
Ovarian cancer84.25.02−0.004.69
Pre-eclampsia or eclampsia71.32.13−0.091.50
Uterine fibroids79.92.047.17 × 10−5.67
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close